"明亮的舌头"和"葡萄酒杯"在肌缩性侧面硬化症中的标志
João Alfredo M M de Barros1, Arthur Felipe B Vasconcelos2, Ana Luísa C B Gomes2
1Departamento de Medicina Interna, Federal University of Paraíba, João Pessoa, Brazil. jalfredommdb@gmail.com.
Neuroradiology
|January 8, 2026
概括
本案例研究详细介绍了一位患有进展性神经症状的患者,最终被诊断为肌缩侧面硬化症 (ALS). 经典的MRI发现支持了这种运动神经元疾病的诊断.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 医疗成像医学成像
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元.
- 早期诊断对于患者管理和研究至关重要.
- 了解特征性成像发现有助于区分ALS与其他神经疾病.
研究的目的:
- 介绍一个关于肌缩侧面硬化症 (ALS) 的案例研究.
- 为了说明与ALS相关的经典磁共振成像 (MRI) 发现.
- 强调神经成像在诊断运动神经元疾病中的作用.
主要方法:
- 一个详细的临床病例介绍一个43岁的男性患者.
- 脑磁共振成像 (MRI) 包括T2/FLAIR和扩散权重成像 (DWI).
- 电神经图 (EMG) 用于电生理学确认.
主要成果:
- 患者表现出渐进的症状,包括腿部单,性性关节障碍,四,步态障碍,肌肉缩,软弱和结.
- 大脑MRI揭示了皮质脊髓通道的特征性超强度,包括"明亮的舌头标志"和"葡萄酒杯标志".
- 电神经图证实了对肌缩性侧面硬化症的诊断.
结论:
- 这种病例表明了氨缩侧面硬化症 (ALS) 的典型临床进展和经典神经成像发现.
- 在MRI上的"明亮的舌头标志"和"葡萄酒杯标志"是诊断ALS的有价值指标.
- 综合的临床,成像和电生理学数据对于准确诊断ALS至关重要.
相关概念视频
Amyloid Fibrils
6.3K
6.3K
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
Cross-bridge Cycle
122.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
122.1K
Visual Agnosia
943
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
943


